VCYT logo

Veracyte (VCYT) Operating Expenses

Annual Operating Expenses

$265.59 M
+$31.98 M+13.69%

December 31, 2023


Summary


Performance

VCYT Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVCYTexpensesmetrics:

Quarterly Operating Expenses

$66.34 M
-$6.61 M-9.07%

September 30, 2024


Summary


Performance

VCYT Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVCYTexpensesmetrics:

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

VCYT Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+13.7%-23.1%
3 y3 years+138.4%+20.6%
5 y5 years+227.2%+180.8%

VCYT Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+17.8%-23.1%+22.9%
5 y5-yearat high+168.3%-23.1%+175.3%
alltimeall timeat high+1672.3%-23.1%+973.6%

Veracyte Operating Expenses History

DateAnnualQuarterly
Sep 2024
-
$66.34 M(-9.1%)
Jun 2024
-
$72.95 M(+5.7%)
Mar 2024
-
$69.04 M(-19.9%)
Dec 2023
$265.59 M(+13.7%)
$86.23 M(+59.8%)
Sep 2023
-
$53.97 M(-17.4%)
Jun 2023
-
$65.35 M(+1.7%)
Mar 2023
-
$64.27 M(+8.5%)
Dec 2022
$233.61 M(+3.6%)
$59.25 M(+1.6%)
Sep 2022
-
$58.30 M(+1.2%)
Jun 2022
-
$57.63 M(-1.4%)
Mar 2022
-
$58.43 M(+4.9%)
Dec 2021
$225.48 M(+102.4%)
$55.67 M(+1.2%)
Sep 2021
-
$54.99 M(+21.9%)
Jun 2021
-
$45.11 M(-35.3%)
Mar 2021
-
$69.72 M(+121.9%)
Dec 2020
$111.42 M(+12.6%)
$31.42 M(+26.6%)
Sep 2020
-
$24.82 M(+3.0%)
Jun 2020
-
$24.10 M(-22.5%)
Mar 2020
-
$31.08 M(+11.8%)
Dec 2019
$98.97 M(+21.9%)
$27.81 M(+17.7%)
Sep 2019
-
$23.62 M(-3.4%)
Jun 2019
-
$24.46 M(+6.0%)
Mar 2019
-
$23.08 M(+14.8%)
Dec 2018
$81.16 M
$20.10 M(+3.0%)
Sep 2018
-
$19.51 M(-4.5%)
DateAnnualQuarterly
Jun 2018
-
$20.42 M(-3.3%)
Mar 2018
-
$21.13 M(+18.2%)
Dec 2017
$70.30 M(+2.7%)
$17.87 M(+6.9%)
Sep 2017
-
$16.72 M(-7.4%)
Jun 2017
-
$18.05 M(+2.3%)
Mar 2017
-
$17.65 M(+14.5%)
Dec 2016
$68.43 M(+11.3%)
$15.41 M(-10.0%)
Sep 2016
-
$17.12 M(-9.3%)
Jun 2016
-
$18.87 M(+10.8%)
Mar 2016
-
$17.02 M(+7.6%)
Dec 2015
$61.47 M(+21.5%)
$15.82 M(+1.4%)
Sep 2015
-
$15.61 M(-1.5%)
Jun 2015
-
$15.84 M(+11.5%)
Mar 2015
-
$14.21 M(-7.7%)
Dec 2014
$50.59 M(+55.9%)
$15.39 M(+14.2%)
Sep 2014
-
$13.48 M(+19.6%)
Jun 2014
-
$11.27 M(+7.9%)
Mar 2014
-
$10.44 M(+14.4%)
Dec 2013
$32.45 M(+41.3%)
$9.13 M(+6.6%)
Sep 2013
-
$8.56 M(+18.0%)
Jun 2013
-
$7.25 M(-3.3%)
Mar 2013
-
$7.50 M(+7.6%)
Dec 2012
$22.97 M(+53.3%)
$6.97 M(+12.8%)
Sep 2012
-
$6.18 M
Dec 2011
$14.99 M
-

FAQ

  • What is Veracyte annual total operating expenses?
  • What is the all time high annual operating expenses for Veracyte?
  • What is Veracyte annual operating expenses year-on-year change?
  • What is Veracyte quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Veracyte?
  • What is Veracyte quarterly operating expenses year-on-year change?

What is Veracyte annual total operating expenses?

The current annual operating expenses of VCYT is $265.59 M

What is the all time high annual operating expenses for Veracyte?

Veracyte all-time high annual total operating expenses is $265.59 M

What is Veracyte annual operating expenses year-on-year change?

Over the past year, VCYT annual total operating expenses has changed by +$31.98 M (+13.69%)

What is Veracyte quarterly total operating expenses?

The current quarterly operating expenses of VCYT is $66.34 M

What is the all time high quarterly operating expenses for Veracyte?

Veracyte all-time high quarterly total operating expenses is $86.23 M

What is Veracyte quarterly operating expenses year-on-year change?

Over the past year, VCYT quarterly total operating expenses has changed by -$19.89 M (-23.06%)